On March 5, 2018 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small-molecule drugs that address cancer, liver disease and inflammatory diseases, reported that it will be presenting at the inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 8:30 AM PST (Press release, Can-Fite BioPharma, MAR 5, 2018, View Source [SID1234524642]). Can-Fite CEO, Dr. Pnina Fishman, will be delivering a corporate presentation and conducting a Q&A session with the investment community.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference will be held via webcast and will feature over 60 companies in the small / micro-cap space.